These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

641 related items for PubMed ID: 18356634

  • 1. Acute ischemic coronary artery disease and ischemic stroke: similarities and differences.
    Fisher M, Folland E.
    Am J Ther; 2008; 15(2):137-49. PubMed ID: 18356634
    [Abstract] [Full Text] [Related]

  • 2. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH.
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [Abstract] [Full Text] [Related]

  • 3. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
    Hennekens CH, Schneider WR.
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
    [Abstract] [Full Text] [Related]

  • 4. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP, Saseen JJ.
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [Abstract] [Full Text] [Related]

  • 5. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS, Bajorek BV.
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [Abstract] [Full Text] [Related]

  • 6. Antiplatelet agents and randomized trials.
    Diener HC.
    Rev Neurol Dis; 2007 Dec; 4(4):177-83. PubMed ID: 18195669
    [Abstract] [Full Text] [Related]

  • 7. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.
    Toth PP.
    Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814
    [Abstract] [Full Text] [Related]

  • 8. Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry).
    Koeth O, Zahn R, Gitt AK, Bauer T, Juenger C, Senges J, Zeymer U, Maximal Individual Therapy in Acute Myocardial Infarction Plus Study Group.
    Am J Cardiol; 2009 Oct 15; 104(8):1074-7. PubMed ID: 19801027
    [Abstract] [Full Text] [Related]

  • 9. The approach to optimizing stroke care.
    Panagos PD.
    Am J Emerg Med; 2008 Sep 15; 26(7):808-16. PubMed ID: 18774049
    [Abstract] [Full Text] [Related]

  • 10. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
    Gebel JM.
    J Am Coll Cardiol; 2005 Sep 06; 46(5):752-5. PubMed ID: 16139120
    [Abstract] [Full Text] [Related]

  • 11. Antiplatelet therapy in the treatment of atherothrombotic disease: considering the evidence.
    Aronow WS.
    Geriatrics; 2007 Apr 06; 62(4):12-24. PubMed ID: 17408314
    [Abstract] [Full Text] [Related]

  • 12. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
    Diener HC.
    Int J Stroke; 2006 Feb 06; 1(1):4-8. PubMed ID: 18706062
    [Abstract] [Full Text] [Related]

  • 13. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS.
    Int J Clin Pract; 2007 Oct 06; 61(10):1739-48. PubMed ID: 17877660
    [Abstract] [Full Text] [Related]

  • 14. Optimal medical management of peripheral arterial disease.
    Rice TW, Lumsden AB.
    Vasc Endovascular Surg; 2006 Oct 06; 40(4):312-27. PubMed ID: 16959725
    [Abstract] [Full Text] [Related]

  • 15. Adding aspirin to clopidogrel after TIA and ischemic stroke: benefits do not match risks.
    Hankey GJ, Eikelboom JW.
    Neurology; 2005 Apr 12; 64(7):1117-21. PubMed ID: 15824331
    [Abstract] [Full Text] [Related]

  • 16. Recent clinical trials of antiplatelet therapy in secondary stroke prevention: expectations and results for application in primary care settings.
    Lutsep HL.
    Am J Med; 2009 Apr 12; 122(4 Suppl 2):S21-31. PubMed ID: 19332240
    [Abstract] [Full Text] [Related]

  • 17. Antiplatelet drugs for ischemic stroke prevention.
    Leys D, Balucani C, Cordonnier C.
    Cerebrovasc Dis; 2009 Apr 12; 27 Suppl 1():120-5. PubMed ID: 19342841
    [Abstract] [Full Text] [Related]

  • 18. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
    Prescrire Int; 2009 Oct 12; 18(103):193-5. PubMed ID: 19877380
    [Abstract] [Full Text] [Related]

  • 19. Residual risk for secondary ischemic events in patients with atherothrombotic disease: opportunity for future improvements in patient care.
    Pepine CJ.
    Ann Med; 2010 Oct 12; 42(1):19-35. PubMed ID: 20092398
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.